Current Liabilities
Current Debt
Bristol-Myers Squibb Current Debt decreased by 56.2% to $1.98B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.4%, from $2.05B to $1.98B. Over 5 years (FY 2020 to FY 2025), Current Debt shows a downward trend with a -3.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase signals a looming requirement for cash or a need to refinance existing debt in the near term.
Detailed definition
The segment of a company's total long-term debt obligations that is scheduled for repayment within the upcoming fiscal y...
Peer comparison
This metric is compared against current assets to determine if the company can meet its immediate debt obligations without external financing.
Metric ID:
current_portion_long_term_debtHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $63.00M | $81.00M | $4.95B | $130.00M | $151.00M | $107.00M | $4.26B | $155.00M | $125.00M | $164.00M | $3.12B | $6.19B | $3.53B | $1.08B | $2.05B | $3.55B | $4.72B | $4.51B | $1.98B |
| QoQ Change | — | +28.6% | >999% | -97.4% | +16.2% | -29.1% | >999% | -96.4% | -19.4% | +31.2% | >999% | +98.5% | -43.0% | -69.5% | +89.8% | +73.7% | +32.7% | -4.4% | -56.2% |
| YoY Change | — | — | — | — | +139.7% | +32.1% | -13.8% | +19.2% | -17.2% | +53.3% | -26.9% | >999% | >999% | +557.3% | -34.4% | -42.6% | +33.5% | +318.3% | -3.4% |
Range$63.00M – $6.19B
CAGR+115.1%
Avg YoY Growth+508.9%
Median YoY Growth+32.1%
Current Streak2 quarters decline
Current Debt at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's current debt?
- Bristol-Myers Squibb (BMY) reported current debt of $1.98B in Q4 2025.
- How has Bristol-Myers Squibb's current debt changed year-over-year?
- Bristol-Myers Squibb's current debt decreased by 3.4% year-over-year, from $2.05B to $1.98B.
- What is the long-term trend for Bristol-Myers Squibb's current debt?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's current debt has grown at a -3.3% compound annual growth rate (CAGR), from $2.34B to $1.98B.
- What does current debt mean?
- The part of long-term loans that must be paid back within the next 12 months.